FDA cancels drug sale licences of Cipla Pharma & Life Sciences' Pune Carry and Forwarding unit

FDA Cancels Cipla Pharma & Life Sciences’ Pune Unit Drug Sale Licence

The FDA said in a statement issued on Friday that the cancellation came into effect on August 27, following an inspection of its main warehouse at Wadki in Pune district.

FDA cancels Cipla Pune unit's licence over Reactin Plus storage, record lapses

The action was taken after an inspection of the company's Wadki facility found discrepancies between physical stock and computerised records, lapses in stock management and inadequate storage arrangements.

Maharashtra FDA Cancels Cipla Unit’s Drug Sales Licence Over Storage, Regulatory Violations | 📰 LatestLY

The Maharashtra Food and Drug Administration (FDA) has cancelled the drug sales licences of Cipla Pharma & Life Sciences’ Carrying and Forwarding (C&F) unit in Pune, citing storage deficiencies and regulatory non-compliance. 📰 Maharashtra FDA Cancels Cipla Unit’s Drug Sales Licence Over Storage, Regulatory Violations.

FDA cancels drug sale licences of Cipla Pharma & Life Sciences' Pune Carry and Forwarding unit

The regulator had found that medicines were stored directly on the floor and flagged deficiencies in procedures for handling expired medicines

Misbranding, storage lapses: FDA cancels Cipla Pune unit’s drug licence over Reactin Plus violations

The Maharashtra Food and Drug Administration has revoked Cipla's licenses to sell Reactin Plus Tablets due to serious violations in packaging and storage practices. Medicines were improperly stored on the floor, and the handling of expired products was inadequate. Cipla also failed to comply with the necessary recall protocols for misbranded drugs. The authorities emphasized that stringent measures will be implemented to ensure adherence to drug…